Loading clinical trials...
Loading clinical trials...
Currently, the molecular characterization of onco-hematological, onco-immunological and hematological diseases, at onset or in relapse, of patients with suspected diagnosis afferent to the CROP center...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Meyer Children's Hospital IRCCS
NCT07402057 · Oncologic Diseases, Cancer
NCT07435597 · Oncologic Disease, Chemotherapy
NCT07294040 · Post-induction Hypotension (PIH), Geriatric Patient, and more
NCT07257640 · Hematologic Diseases, Neoplasms
NCT07175350 · Oncologic Diseases
Meyer Children's Hospital IRCCS
Florence
Azienda Ospedaliero-Universitaria Pisana
Pisa
Azienda Ospedaliero-Universitaria Senese
Siena
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions